Hsiu-Lien Yeh

Hsiu-Lien Yeh

Auto-generated profile, based on publicly available information

Hsiu-Lien Yeh

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2020 in Oncogene
Verified
Journal Article
Closed access
PDF file
SLShian-Ren Lin
Shian-Ren Lin
YWYu-Ching Wen
Yu-Ching Wen
HYHsiu-Lien Yeh
Hsiu-Lien Yeh
KJKuo-Ching Jiang
Kuo-Ching Jiang
WCWei-Hao Chen
Wei-Hao Chen
YLYen-Nien Liu
Yen-Nien Liu

20 November 2021 in Oncogenesis
Verified
Journal Article
Open access
PDF file
YWYu-Ching Wen
Yu-Ching Wen
YLYen-Nien Liu
Yen-Nien Liu
HYHsiu-Lien Yeh
Hsiu-Lien Yeh
WCWei-Hao Chen
Wei-Hao Chen
KJKuo-Ching Jiang
Kuo-Ching Jiang
Michael HsiaoMichael Hsiao
Michael Hsiao
Neuroendocrine differentiation (NED) is associated with WNT signaling activation and can be significantly observed after failure of androgen-deprivation therapy (ADT) for prostatic adenocarcinomas. Cytokine signaling is stimulated in NED prostate cancer; however, how ADT-upregulated WNT signaling promotes activation of cytokine signaling and contributes to NED of prostate cancer is poorly understood. In this study, we identified ADT-mediated upregulation of transcription factor 7 like 1 (TCF7L1), which increases the cytokine response and enhances NED of prostate cancer through interleukin (IL)-8/C-X-C motif chemokine receptor type 2 (CXCR2) signaling activation. ADT induced the secretion of WNT4 which upon engagement of TCF7L1 in prostate cancer cells, enhanced IL-8 and CXCR2 expressions. TCF7L1 directly binds to the regulatory sequence region of IL-8 and CXCR2 through WNT4 activation, thus upregulating IL-8/CXCR2 signaling-driven NED and cell motility. Analysis of prostate tissue samples collected from small-cell neuroendocrine prostate cancer (SCPC) and castration-resistant prostate cancer (CRPC) tumors showed an increased intensity of nuclear TCF7L1 associated with CXCR2. Our results suggest that induction of WNT4/TCF7L1 results in increased NED and malignancy in prostate cancer that is linked to dysregulation of androgen receptor signaling and activation of the IL-8/CXCR2 pathway.

11 June 2024 in Science Signaling
Verified
Journal Article
Closed access
YLYen-Nien Liu
Yen-Nien Liu
HYHsiu-Lien Yeh
Hsiu-Lien Yeh
WCWei-Hao Chen
Wei-Hao Chen
KJKuo-Ching Jiang
Kuo-Ching Jiang
HLHan-Ru Li
Han-Ru Li
YWYu-Ching Wen
Yu-Ching Wen
Neuroendocrine prostate cancer (PCa) (NEPC), an aggressive subtype that is associated with poor prognosis, may arise after androgen deprivation therapy (ADT). We investigated the molecular mechanisms by which ADT induces neuroendocrine differentiation in advanced PCa. We found that transmembrane protein 1 (MCTP1), which has putative Ca 2+ sensing function and multiple Ca 2+ -binding C2 domains, was abundant in samples from patients with advanced PCa. MCTP1 was associated with the expression of the EMT-associated transcription factors ZBTB46, FOXA2, and HIF1A. The increased abundance of MCTP1 promoted PC3 prostate cancer cell migration and neuroendocrine differentiation and was associated with SNAI1-dependent EMT in C4-2 PCa cells after ADT. ZBTB46 interacted with FOXA2 and HIF1A and increased the abundance of MCTP1 in a hypoxia-dependent manner. MCTP1 stimulated Ca 2+ signaling and AKT activation to promote EMT and neuroendocrine differentiation by increasing the SNAI1-dependent expression of EMT and neuroendocrine markers, effects that were blocked by knockdown of MCTP1. These data suggest an oncogenic role for MCTP1 in the maintenance of a rare and aggressive prostate cancer subtype through its response to Ca 2+ and suggest its potential as a therapeutic target.